tiprankstipranks
Trending News
More News >
Bio-Rad Laboratories (BIO)
NYSE:BIO

Bio-Rad Laboratories (BIO) Stock Statistics & Valuation Metrics

Compare
888 Followers

Total Valuation

Bio-Rad Laboratories has a market cap or net worth of $6.34B. The enterprise value is $13.29B.
Market Cap$6.34B
Enterprise Value$13.29B

Share Statistics

Bio-Rad Laboratories has 22,142,422 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,142,422
Owned by Insiders
Owned by Institutions

Financial Efficiency

Bio-Rad Laboratories’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is 2.37%.
Return on Equity (ROE)-0.28
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)2.37%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee333.31K
Profits Per Employee-239.51K
Employee Count7,700
Asset Turnover0.27
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Bio-Rad Laboratories is -5.03. Bio-Rad Laboratories’s PEG ratio is 0.02.
PE Ratio-5.03
PS Ratio0.00
PB Ratio1.30
Price to Fair Value1.41
Price to FCF155.99
Price to Operating Cash Flow64.41
PEG Ratio0.02

Income Statement

In the last 12 months, Bio-Rad Laboratories had revenue of 2.57B and earned -1.84B in profits. Earnings per share was -65.36.
Revenue2.57B
Gross Profit1.38B
Operating Income269.00M
Pretax Income-2.34B
Net Income-1.84B
EBITDA-2.10B
Earnings Per Share (EPS)-65.36

Cash Flow

In the last 12 months, operating cash flow was 515.31M and capital expenditures -183.22M, giving a free cash flow of 332.08M billion.
Operating Cash Flow515.31M
Free Cash Flow332.08M
Free Cash Flow per Share15.00

Dividends & Yields

Bio-Rad Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.91
52-Week Price Change-23.28%
50-Day Moving Average235.94
200-Day Moving Average299.83
Relative Strength Index (RSI)46.17
Average Volume (3m)354.06K

Important Dates

Bio-Rad Laboratories upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateMay 1, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend Date

Financial Position

Bio-Rad Laboratories as a current ratio of 6.48, with Debt / Equity ratio of 12.46%
Current Ratio6.48
Quick Ratio6.48
Debt to Market Cap0.13
Net Debt to EBITDA-0.42
Interest Coverage Ratio5.50

Taxes

In the past 12 months, Bio-Rad Laboratories has paid -498.30M in taxes.
Income Tax-498.30M
Effective Tax Rate0.21

Enterprise Valuation

Bio-Rad Laboratories EV to EBITDA ratio is -4.83, with an EV/FCF ratio of 38.15.
EV to Sales3.96
EV to EBITDA-4.83
EV to Free Cash Flow38.15
EV to Operating Cash Flow22.31

Balance Sheet

Bio-Rad Laboratories has $1.66M in cash and marketable securities with $1.37B in debt, giving a net cash position of $1.37B billion.
Cash & Marketable Securities$1.66M
Total Debt$1.37B
Net Cash$1.37B
Net Cash Per Share$61.77
Tangible Book Value Per Share$207.88

Margins

Gross margin is 55.93%, with operating margin of 10.48%, and net profit margin of -71.86%.
Gross Margin55.93%
Operating Margin10.48%
Pretax Margin-91.27%
Net Profit Margin-71.86%
EBITDA Margin-81.85%
EBIT Margin-89.37%

Analyst Forecast

The average price target for Bio-Rad Laboratories is $314.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$314.20
Price Target Upside38.47% Upside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast-2.46%
EPS Growth Forecast-637.11%

Scores

Smart Score7
AI Score49.4
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis